Radiotheranostics is here to help
The COVID-19 pandemic did not diminish interest in radiotheranostics. However, the demand for visualization of pathological processes using cross-sectional and hybrid imaging (CT, MRI, SPECT, and PET) is increased. Over the past 15 months, the world has seen an exponential increase in investment in...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Eco-Vector
2021-10-01
|
| Series: | Digital Diagnostics |
| Subjects: | |
| Online Access: | https://jdigitaldiagnostics.com/DD/article/viewFile/77959/pdf |
| _version_ | 1798033586873434112 |
|---|---|
| author | Rumyantsev O. Rumyantsev |
| author_facet | Rumyantsev O. Rumyantsev |
| author_sort | Rumyantsev O. Rumyantsev |
| collection | DOAJ |
| description | The COVID-19 pandemic did not diminish interest in radiotheranostics. However, the demand for visualization of pathological processes using cross-sectional and hybrid imaging (CT, MRI, SPECT, and PET) is increased. Over the past 15 months, the world has seen an exponential increase in investment in new radiopharmaceuticals for radiotheranostics. The list of antibodies and ligands labeled with "medical" radioactive isotopes is expanding as the molecular mechanisms of regulation and implementation of metabolic processes become clearer. The range of diagnostic and therapeutic radioactive isotopes is also expanding, ultimately increasing the range and availability of radiotherapy in nuclear medicine centers worldwide. It is necessary to unite the efforts of physicists, radiopharmacists, chemists, biologists, doctors, and mathematicians to develop radio technology. Usage and improvement of personalized dosimetry for planning radionuclide therapy is also a priority. For example, the International Foundation Oncidium helps with information and exchange of experience, while the international diagnostic study NOBLE increases the availability and reduces the cost of PSMA receptor scintigraphy. An association for the development of theranostics was created to intensify the integration renewal of nuclear medicine. |
| first_indexed | 2024-04-11T20:32:42Z |
| format | Article |
| id | doaj.art-bc27a5c832c3498881857af71bbe28bb |
| institution | Directory Open Access Journal |
| issn | 2712-8490 2712-8962 |
| language | English |
| last_indexed | 2024-04-11T20:32:42Z |
| publishDate | 2021-10-01 |
| publisher | Eco-Vector |
| record_format | Article |
| series | Digital Diagnostics |
| spelling | doaj.art-bc27a5c832c3498881857af71bbe28bb2022-12-22T04:04:27ZengEco-VectorDigital Diagnostics2712-84902712-89622021-10-012341041610.17816/DD7795972527Radiotheranostics is here to helpRumyantsev O. Rumyantsev0https://orcid.org/0000-0002-7721-634XSOGAZ International Medical CenterThe COVID-19 pandemic did not diminish interest in radiotheranostics. However, the demand for visualization of pathological processes using cross-sectional and hybrid imaging (CT, MRI, SPECT, and PET) is increased. Over the past 15 months, the world has seen an exponential increase in investment in new radiopharmaceuticals for radiotheranostics. The list of antibodies and ligands labeled with "medical" radioactive isotopes is expanding as the molecular mechanisms of regulation and implementation of metabolic processes become clearer. The range of diagnostic and therapeutic radioactive isotopes is also expanding, ultimately increasing the range and availability of radiotherapy in nuclear medicine centers worldwide. It is necessary to unite the efforts of physicists, radiopharmacists, chemists, biologists, doctors, and mathematicians to develop radio technology. Usage and improvement of personalized dosimetry for planning radionuclide therapy is also a priority. For example, the International Foundation Oncidium helps with information and exchange of experience, while the international diagnostic study NOBLE increases the availability and reduces the cost of PSMA receptor scintigraphy. An association for the development of theranostics was created to intensify the integration renewal of nuclear medicine.https://jdigitaldiagnostics.com/DD/article/viewFile/77959/pdfradiotheranosticscanceroncologypsma |
| spellingShingle | Rumyantsev O. Rumyantsev Radiotheranostics is here to help Digital Diagnostics radiotheranostics cancer oncology psma |
| title | Radiotheranostics is here to help |
| title_full | Radiotheranostics is here to help |
| title_fullStr | Radiotheranostics is here to help |
| title_full_unstemmed | Radiotheranostics is here to help |
| title_short | Radiotheranostics is here to help |
| title_sort | radiotheranostics is here to help |
| topic | radiotheranostics cancer oncology psma |
| url | https://jdigitaldiagnostics.com/DD/article/viewFile/77959/pdf |
| work_keys_str_mv | AT rumyantsevorumyantsev radiotheranosticsisheretohelp |